|
Reference
number | Author (Year) | Type of study | Time period | Number of women | Cohorts (n) | Type of diabetes | Comparison(s) |
|
| [35] | Di Cianni et al. (2008) | Retrospective | to December 31, 2006 | 101 | Glargine (43)
NPH (58) | Type 1 DM | Continuous glargine use throughout pregnancy versus cessation of glargine during pregnancy (replaced w/NPH) |
| [36] | Egerman et al. (2009) | Retrospective | January 2004 to August 2006 | 114 | Glargine (65)
NPH (49) | Pregestational
Gestational | Insulin glargine versus NPH |
| [37] | Fang et al. (2009) | Retrospective | January 2003 to April 2008 | 112 | Pregestational:
glargine (37),
NPH (16)
Gestational:
glargine (15)
NPH (44) | Pregestational
Gestational | Insulin glargine versus NPH Pregestational versus gestational DM |
| [38] | Imbergamo et al. (2008) | Case control | January 2004 to December 2007 | 73 | Glargine (15)
NPH (15)
Control (43)* | Type 1 DM | Insulin glargine versus NPH
Insulin glargine versus control
NPH versus control |
| [39] | Negrato et al. (2010) | Observational prospective | January 2004 to April 2009 | 138 | Pregestational:
glargine (18), NPH (38)
Gestational:
glargine (37), NPH (45) | Pregestational
Gestational | Insulin glargine versus NPH Pregestational versus gestational DM |
| [40] | Poyhonen-Alho et al. (2007) | Case control | January 2003 to December 2005 | 91 | Glargine (42)
NPH (50) | Type 1 DM | Insulin glargine versus NPH |
| [41] | Price et al. (2007) | Case control | January 2002 to December 2005 | 64 | Pregestational:
glargine (10), NPH (10) Gestational:
glargine (22), NPH (22) | Pregestational (type 1 DM)
Gestational | Insulin glargine versus NPH Pregestational versus gestational DM |
| [42] | Smith et al. (2009) | Retrospective | January 2000 to December 2005 | 52 | Glargine (27)
NPH (25) | Pregestational (type 1+2 DM)
Gestational | Insulin glargine versus NPH |
|
